Arteriovenous thrombotic events in a patient with advanced lung cancer following bevacizumab plus chemotherapy: A case report

BACKGROUND: In driver gene-negative non-small cell lung cancer patients who relapse following radical resection, combination chemotherapy using bevacizumab and platinum-based dual drugs is known to increase both progression-free and overall survival. Treatment initially includes bevacizumab, and if...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Ying, Xu, Xiao-Cheng, Hong, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294919/
https://www.ncbi.nlm.nih.gov/pubmed/35979297
http://dx.doi.org/10.12998/wjcc.v10.i19.6507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294919/
https://www.ncbi.nlm.nih.gov/pubmed/35979297
http://dx.doi.org/10.12998/wjcc.v10.i19.6507

Ejemplares similares